A detailed history of Wellington Shields Capital Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wellington Shields Capital Management, LLC holds 7,741 shares of BMY stock, worth $411,743. This represents 0.06% of its overall portfolio holdings.

Number of Shares
7,741
Previous 7,400 4.61%
Holding current value
$411,743
Previous $401,000 19.95%
% of portfolio
0.06%
Previous 0.08%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$40.25 - $52.99 $13,725 - $18,069
341 Added 4.61%
7,741 $321,000
Q1 2024

May 03, 2024

SELL
$47.98 - $54.4 $57,144 - $64,790
-1,191 Reduced 13.86%
7,400 $401,000
Q4 2023

Feb 09, 2024

SELL
$48.48 - $57.85 $7,417 - $8,851
-153 Reduced 1.75%
8,591 $440,000
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $115 - $129
2 Added 0.02%
8,744 $507,000
Q2 2023

Aug 11, 2023

SELL
$63.71 - $70.74 $11,085 - $12,308
-174 Reduced 1.95%
8,742 $559,000
Q1 2023

May 11, 2023

BUY
$65.71 - $74.53 $65 - $74
1 Added 0.01%
8,916 $617,000
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $68 - $81
1 Added 0.01%
8,915 $641,000
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $0 - $76
1 Added 0.01%
8,914 $634,000
Q2 2022

Aug 12, 2022

SELL
$72.62 - $79.98 $21,422 - $23,594
-295 Reduced 3.2%
8,913 $686,000
Q1 2022

May 12, 2022

SELL
$61.48 - $73.72 $1.32 Million - $1.58 Million
-21,453 Reduced 69.97%
9,208 $687,000
Q4 2021

Feb 15, 2022

BUY
$53.63 - $62.52 $804,503 - $937,862
15,001 Added 95.79%
30,661 $1.91 Million
Q3 2021

Nov 10, 2021

SELL
$59.17 - $69.31 $1.14 Million - $1.34 Million
-19,298 Reduced 55.2%
15,660 $927,000
Q2 2021

Aug 13, 2021

SELL
$61.91 - $67.42 $237,920 - $259,095
-3,843 Reduced 9.9%
34,958 $2.34 Million
Q1 2021

May 12, 2021

SELL
$59.34 - $66.74 $49,192 - $55,327
-829 Reduced 2.09%
38,801 $2.45 Million
Q4 2020

Feb 09, 2021

BUY
$57.74 - $65.43 $499,797 - $566,362
8,656 Added 27.95%
39,630 $2.46 Million
Q3 2020

Nov 10, 2020

SELL
$57.43 - $63.64 $173,208 - $191,938
-3,016 Reduced 8.87%
30,974 $1.87 Million
Q2 2020

Aug 05, 2020

SELL
$54.82 - $64.09 $155,579 - $181,887
-2,838 Reduced 7.71%
33,990 $2 Million
Q1 2020

May 07, 2020

BUY
$46.4 - $67.43 $69,043 - $100,335
1,488 Added 4.21%
36,828 $2.05 Million
Q4 2019

Feb 11, 2020

BUY
$49.21 - $64.19 $172,235 - $224,665
3,500 Added 10.99%
35,340 $2.27 Million
Q3 2019

Nov 05, 2019

BUY
$42.77 - $50.71 $17,108 - $20,284
400 Added 1.27%
31,840 $1.62 Million
Q2 2019

Aug 08, 2019

SELL
$44.62 - $49.34 $55,908 - $61,823
-1,253 Reduced 3.83%
31,440 $1.43 Million
Q1 2019

May 10, 2019

SELL
$45.12 - $53.8 $6,768 - $8,070
-150 Reduced 0.46%
32,693 $1.56 Million
Q4 2018

Feb 11, 2019

SELL
$48.76 - $63.23 $114,439 - $148,400
-2,347 Reduced 6.67%
32,843 $1.71 Million
Q3 2018

Nov 06, 2018

SELL
$55.19 - $62.25 $16,557 - $18,675
-300 Reduced 0.85%
35,190 $2.19 Million
Q2 2018

Aug 02, 2018

SELL
$50.53 - $62.98 $279,936 - $348,909
-5,540 Reduced 13.5%
35,490 $1.96 Million
Q1 2018

May 03, 2018

BUY
$59.92 - $68.98 $91,677 - $105,539
1,530 Added 3.87%
41,030 $2.6 Million
Q4 2017

Feb 06, 2018

SELL
$59.94 - $65.35 $125,874 - $137,235
-2,100 Reduced 5.05%
39,500 $2.42 Million
Q3 2017

Nov 06, 2017

BUY
$55.23 - $63.74 $2.3 Million - $2.65 Million
41,600
41,600 $2.65 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Wellington Shields Capital Management, LLC Portfolio

Follow Wellington Shields Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Shields Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Shields Capital Management, LLC with notifications on news.